Thus, monomeric apoE4 binds to Aβ peptide more rapidly than monomeric apoE3 or apoE2, and so it appears that the efficiency of binding correlates inversely with the risk of developing AD pathology [62]. The gene discussed is APOE; the disease is Alzheimer disease.